Jane Street
NVAX icon

Jane Street’s Novavax NVAX Stock Holding History

Jane Street’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.18M Sell
145,300
-514,600
-78% -$4.66M ﹤0.01% 6160
2025
Q4 		$4.43M Sell
659,900
-31,800
-5% -$240K ﹤0.01% 3422
2025
Q3 		$6M Sell
691,700
-124,700
-15% -$971K ﹤0.01% 3157
2025
Q2 		$5.14M Sell
816,400
-19,300
-2% -$128K ﹤0.01% 2956
2025
Q1 		$5.36M Sell
835,700
-1,522,400
-65% -$12.6M ﹤0.01% 2841
2024
Q4 		$19M Sell
2,358,100
-347,600
-13% -$3.35M ﹤0.01% 1298
2024
Q3 		$34.2M Buy
2,705,700
+277,400
+11% +$3.58M 0.01% 887
2024
Q2 		$30.7M Buy
2,428,300
+1,432,000
+144% +$14.4M 0.01% 966
2024
Q1 		$4.76M Buy
996,300
+165,800
+20% +$769K ﹤0.01% 2683
2023
Q4 		$3.99M Buy
830,500
+24,000
+3% +$147K ﹤0.01% 3190
2023
Q3 		$5.84M Buy
806,500
+372,800
+86% +$2.98M ﹤0.01% 2390
2023
Q2 		$3.22M Sell
433,700
-20,400
-4% -$160K ﹤0.01% 3374
2023
Q1 		$3.15M Sell
454,100
-215,500
-32% -$1.98M ﹤0.01% 3074
2022
Q4 		$6.88M Buy
669,600
+315,700
+89% +$5.57M ﹤0.01% 2065
2022
Q3 		$6.44M Sell
353,900
-356,800
-50% -$15.5M ﹤0.01% 2239
2022
Q2 		$36.6M Sell
710,700
-184,700
-21% -$9.57M 0.02% 710
2022
Q1 		$65.9M Sell
895,400
-254,200
-22% -$22.7M 0.02% 557
2021
Q4 		$164M Buy
1,149,600
+421,500
+58% +$72.4M 0.05% 228
2021
Q3 		$151M Buy
728,100
+59,800
+9% +$13.2M 0.05% 240
2021
Q2 		$142M Buy
668,300
+308,400
+86% +$56.5M 0.06% 231
2021
Q1 		$65.3M Sell
359,900
-68,800
-16% -$13.7M 0.03% 400
2020
Q4 		$47.8M Buy
428,700
+13,300
+3% +$1.41M 0.02% 466
2020
Q3 		$45M Sell
415,400
-160,400
-28% -$19.5M 0.03% 427
2020
Q2 		$48M Buy
575,800
+510,900
+787% +$19.5M 0.04% 375
2020
Q1 		$881K Buy
+64,900
New +$549K ﹤0.01% 2950
2016
Q4 		– Sell
-5,165
Closed -$215K – 4435
2016
Q3 		$215K Buy
+5,165
New +$667K ﹤0.01% 3647
2016
Q2 		– Sell
-580
Closed -$60K – 4424
2016
Q1 		$60K Buy
+580
New +$62.2K ﹤0.01% 3941

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street's NVAX Position: Q1 2026 in Review

Jane Street reduced its Novavax (NVAX) stake by 88% in Q1 2026, selling an estimated $4.11M and leaving 64,157 shares worth $522K. The position accounts for ﹤0.01% of the portfolio, ranked #7955.

Jane Street first reported a position in NVAX in Q3 2013 and has held it in 40 quarters since. The position peaked at $93M in Q4 2021. 258 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Jane Street held 64,157 shares of Novavax worth $522K as of Q1 2026.
  • Jane Street sold 453,486 Novavax shares in Q1 2026, an estimated $4.11M.
  • Novavax made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #7955 holding.
  • Jane Street first reported a position in Novavax in Q3 2013 and has held it in 40 quarters since.
  • Jane Street's Novavax position peaked at $93M in Q4 2021.
  • 258 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.